论文部分内容阅读
为评价心房程序起搏治疗阵发性心房颤动 (简称房颤 )的有效性 ,1 1例阵发性房颤患者中 1 0例置入Selec tion90 0E(AF2 .0 )型起搏器、1例置入IntegrityTMAFXDR5346型起搏器。对患者进行术前 1个月和术后 1 ,2个月阵发性房颤事件和SF 36生活质量调查。结果 :患者术后 1 ,2个月较术前 1个月在有症状阵发性房颤事件数和生活质量评分有明显降低 (1 3 .0 1± 8.51 ,9.81± 5 .91vs 2 7.0 0± 1 3 .2 1 ;62 .82± 2 1 .57,55 .73± 1 8.48vs 1 1 0 .0 0± 1 6 .57,P值均<0 .0 5) ,术后 2个月较术后 1个月有症状阵发性房颤事件数 (9.81± 5 .91vs 1 3 .0 1± 8.51 )、阵发性房颤总数 (2 1 0 .0 0± 2 69.59vs 30 9.82± 41 8.1 4 )、房颤总持续时间 (6 .0 0± 4 .1 4dvs 7.87± 4 .2 6d)、房颤负荷 (2 0 .0 1 %± 1 3 .80 %vs 2 6 .2 4 %± 1 4 .2 0 % )及生活质量评分 (55 .73± 1 8.48vs 62 .82± 2 1 .57)均降低 (P值均 <0 .0 5)。结论 :心房程序起搏能够减少阵发性房颤事件的发生 ,降低房颤负荷 ,有望成为阵发性房颤药物治疗的重要辅助手段
To evaluate the effectiveness of atrial pacing in the treatment of paroxysmal atrial fibrillation (AF), 11 patients with paroxysmal atrial fibrillation were placed in a Selec tion 90 0E (AF2 .0) pacemaker, 1 Example Into the IntegrityTMAFXDR5346 pacemaker. The patients were investigated for paroxysmal atrial fibrillation events and SF 36 quality of life at 1 month and at 1 and 2 months after surgery. Results: The number of symptomatic paroxysmal atrial fibrillation and quality of life scores in patients with symptomatic paroxysmal atrial fibrillation at 1 month and 2 months after operation were significantly lower (13.01 ± 8.51, 9.81 ± 5.91 vs 2 7.0 0 ± 1 3 .2 1; 62 .82 ± 2 1 .57,55 .73 ± 1 8.48vs 1 1 0 .0 ± 1 6 .57, both P <0.05), and 2 months after operation The number of symptomatic paroxysmal atrial fibrillation (9.81 ± 5.91 vs 13.01 ± 8.51) and the total number of paroxysmal atrial fibrillation (20.0 ± 2 69.59 vs 30 9.82 ± 41 8.1 4), total duration of atrial fibrillation (6.0 ± 4.14 days vs 7.87 ± 4.26 days), atrial fibrillation load (20.0 ± 1.3% .80% vs 26.44 % ± 14.2%) and quality of life score (55.73 ± 1 8.48 vs 62.81 ± 21.57) (P <0.05). Conclusion: Atrial pacing can reduce the incidence of paroxysmal atrial fibrillation and reduce the load of atrial fibrillation, which is expected to become an important adjunct to the treatment of paroxysmal atrial fibrillation